Bayaca, Artemio D.

HRN: 21-28-23  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/27/2022
05/04/2022
IVT
4.5g
Q6
HAP
Waiting Final Action 
05/04/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/04/2022
05/11/2022
IV
4.5g
Q6
Septic Shock Sec To HAP?
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: